[Clinical pharmacology and therapeutic effect of suloctidil on intellectual and motor disorders of cerebrovascular origin].
D000368:Aged; D001927:Brain Diseases / Q000209:etiology; D002245:Carbon Dioxide; D002561:Cerebrovascular Disorders / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D004569:Electroencephalography; D005260:Female; D005947:Glucose; D006801:Humans; D007360:Intelligence / Q000187:drug effects; D008297:Male; D008875:Middle Aged; D011187:Posture; D011412:Propanolamines / Q000627:therapeutic use*; D011594:Psychometrics; D011596:Psychomotor Disorders / Q000209:etiology; D014665:Vasodilator Agents / Q000494:pharmacology / Q000627:therapeutic use*
D011412:Propanolamines; D014665:Vasodilator Agents; D002245:Carbon Dioxide; D005947:Glucose
Pharmacologie clinique et d'activité thérapeutique: action du duloctidil sur les troubles intellectuels et moteurs d'origine vasculaire cérébrale.